# Trio-Tech International: financial statements, quarterly

TRT · Nasdaq · CIK 732026 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/trt.md) · [Financials](/companies/trt/financials.md) · [Filings](/companies/trt/filings.md) · [Insiders](/companies/trt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [10.0](/filings/0001437749-24-034421.md) | [12.2](/filings/0001437749-25-003692.md) | [10.4](/filings/0001437749-25-016318.md) | [9.7 d](/filings/0001437749-25-029455.md) | [9.8](/filings/0001437749-25-034999.md) | [8.6](/filings/0001437749-26-004010.md) | [7.4](/filings/0001437749-26-016914.md) | [10.7 d](/filings/0001437749-26-031124.md) | [15.5](/filings/0001437749-25-034999.md) | [15.6](/filings/0001437749-26-004010.md) | [16.5](/filings/0001437749-26-016914.md) | [14.9 d](/filings/0001437749-26-031124.md) |
| Cost of revenue | $m | [7.4](/filings/0001437749-24-034421.md) | [9.3](/filings/0001437749-25-003692.md) | [7.7](/filings/0001437749-25-016318.md) | [7.1 d](/filings/0001437749-25-029455.md) | [7.5](/filings/0001437749-25-034999.md) | [6.4](/filings/0001437749-26-004010.md) | [5.4](/filings/0001437749-26-016914.md) | [8.0 d](/filings/0001437749-26-031124.md) | [12.9](/filings/0001437749-25-034999.md) | [13.2](/filings/0001437749-26-004010.md) | [14.0](/filings/0001437749-26-016914.md) | [12.2 d](/filings/0001437749-26-031124.md) |
| Gross profit | $m | [2.5](/filings/0001437749-24-034421.md) | [2.9](/filings/0001437749-25-003692.md) | [2.7](/filings/0001437749-25-016318.md) | [2.7 d](/filings/0001437749-25-029455.md) | [2.3](/filings/0001437749-25-034999.md) | [2.2](/filings/0001437749-26-004010.md) | [2.0](/filings/0001437749-26-016914.md) | [2.6 d](/filings/0001437749-26-031124.md) | [2.6](/filings/0001437749-25-034999.md) | [2.5](/filings/0001437749-26-004010.md) | [2.6](/filings/0001437749-26-016914.md) | [2.8 d](/filings/0001437749-26-031124.md) |
| Research and development | $m | [0.1](/filings/0001437749-24-034421.md) | [0.1](/filings/0001437749-25-003692.md) | [0.1](/filings/0001437749-25-016318.md) | [0.1 d](/filings/0001437749-25-029455.md) | [0.1](/filings/0001437749-25-034999.md) | [0.1](/filings/0001437749-26-004010.md) | [0.1](/filings/0001437749-26-016914.md) | [0.1 d](/filings/0001437749-26-031124.md) | [0.1](/filings/0001437749-25-034999.md) | [0.1](/filings/0001437749-26-004010.md) | [0.1](/filings/0001437749-26-016914.md) | [0.1 d](/filings/0001437749-26-031124.md) |
| Operating income | $m | [(0.0)](/filings/0001437749-24-034421.md) | [0.7](/filings/0001437749-25-003692.md) | [0.1](/filings/0001437749-25-016318.md) | [0.4 d](/filings/0001437749-25-029455.md) | [0.1](/filings/0001437749-25-034999.md) | [(0.0)](/filings/0001437749-26-004010.md) | [(0.3)](/filings/0001437749-26-016914.md) | [0.5 d](/filings/0001437749-26-031124.md) | [0.0](/filings/0001437749-25-034999.md) | [0.1](/filings/0001437749-26-004010.md) | [(0.1)](/filings/0001437749-26-016914.md) | [(0.3) d](/filings/0001437749-26-031124.md) |
| Interest expense | $m | [0.0](/filings/0001437749-23-031430.md) | [0.0](/filings/0001437749-24-003714.md) | [0.0](/filings/0001437749-24-016136.md) | [0.0 d](/filings/0001437749-25-029455.md) | [0.0](/filings/0001437749-25-034999.md) | [0.0](/filings/0001437749-26-004010.md) | [0.0](/filings/0001437749-26-016914.md) | [0.0 d](/filings/0001437749-26-031124.md) | [0.0](/filings/0001437749-25-034999.md) | [0.0](/filings/0001437749-26-004010.md) | [0.0](/filings/0001437749-26-016914.md) | [0.0 d](/filings/0001437749-26-031124.md) |
| Income tax | $m | [0.0](/filings/0001437749-24-034421.md) | [0.1](/filings/0001437749-25-003692.md) | [0.1](/filings/0001437749-25-016318.md) | [0.2 d](/filings/0001437749-25-029455.md) | [0.1](/filings/0001437749-25-034999.md) | [0.1](/filings/0001437749-26-004010.md) | [0.0](/filings/0001437749-26-016914.md) | [(0.0) d](/filings/0001437749-26-031124.md) | [0.1](/filings/0001437749-25-034999.md) | [0.1](/filings/0001437749-26-004010.md) | [0.1](/filings/0001437749-26-016914.md) | [(0.1) d](/filings/0001437749-26-031124.md) |
| Net income | $m | [0.2](/filings/0001437749-24-034421.md) | [0.5](/filings/0001437749-25-003692.md) | [0.1](/filings/0001437749-25-016318.md) | [0.2 d](/filings/0001437749-25-029455.md) | [(0.2)](/filings/0001437749-25-034999.md) | [0.5](/filings/0001437749-26-004010.md) | [(0.5)](/filings/0001437749-26-016914.md) | [0.2 d](/filings/0001437749-26-031124.md) | [0.1](/filings/0001437749-25-034999.md) | [0.1](/filings/0001437749-26-004010.md) | [(0.0)](/filings/0001437749-26-016914.md) | [(0.2) d](/filings/0001437749-26-031124.md) |
| Diluted EPS | $ per share | [0.05](/filings/0001437749-24-034421.md) | [0.12](/filings/0001437749-25-003692.md) | [0.02](/filings/0001437749-25-016318.md) | not reported | [(0.06)](/filings/0001437749-25-034999.md) | [0.06](/filings/0001437749-26-004010.md) | [(0.06)](/filings/0001437749-26-016914.md) | not reported | [0.02](/filings/0001437749-25-034999.md) | [0.01](/filings/0001437749-26-004010.md) | [0.00](/filings/0001437749-26-016914.md) | not reported |
| Basic EPS | $ per share | [0.06](/filings/0001437749-24-034421.md) | [0.12](/filings/0001437749-25-003692.md) | [0.02](/filings/0001437749-25-016318.md) | not reported | [(0.06)](/filings/0001437749-25-034999.md) | [0.06](/filings/0001437749-26-004010.md) | [(0.06)](/filings/0001437749-26-016914.md) | not reported | [0.02](/filings/0001437749-25-034999.md) | [0.01](/filings/0001437749-26-004010.md) | [0.00](/filings/0001437749-26-016914.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.3](/filings/0001437749-23-031430.md) | [11.0](/filings/0001437749-24-003714.md) | [10.7](/filings/0001437749-24-016136.md) | [10.0](/filings/0001437749-25-029455.md) | [8.9](/filings/0001437749-24-034421.md) | [10.3](/filings/0001437749-25-003692.md) | [11.0](/filings/0001437749-25-016318.md) | [10.9](/filings/0001437749-26-031124.md) | [12.3](/filings/0001437749-25-034999.md) | [12.4](/filings/0001437749-26-004010.md) | [13.0](/filings/0001437749-26-016914.md) | [21.4](/filings/0001437749-26-031124.md) |
| Current assets | $m | [32.4](/filings/0001437749-23-031430.md) | [35.1](/filings/0001437749-24-003714.md) | [32.3](/filings/0001437749-24-016136.md) | [32.2](/filings/0001437749-25-029455.md) | [32.5](/filings/0001437749-24-034421.md) | [30.6](/filings/0001437749-25-003692.md) | [30.9](/filings/0001437749-25-016318.md) | [31.6](/filings/0001437749-26-031124.md) | [37.6](/filings/0001437749-25-034999.md) | [34.7](/filings/0001437749-26-004010.md) | [33.3](/filings/0001437749-26-016914.md) | [45.3](/filings/0001437749-26-031124.md) |
| Total assets | $m | [44.7](/filings/0001437749-24-034421.md) | [46.6](/filings/0001437749-25-003692.md) | [43.1](/filings/0001437749-25-016318.md) | [42.5](/filings/0001437749-25-029455.md) | [42.9](/filings/0001437749-25-034999.md) | [39.8](/filings/0001437749-26-004010.md) | [40.0](/filings/0001437749-26-016914.md) | [41.1](/filings/0001437749-26-031124.md) | [47.4](/filings/0001437749-25-034999.md) | [45.7](/filings/0001437749-26-004010.md) | [44.7](/filings/0001437749-26-016914.md) | [60.7](/filings/0001437749-26-031124.md) |
| Current liabilities | $m | [12.5](/filings/0001437749-23-031430.md) | [12.9](/filings/0001437749-24-003714.md) | [9.8](/filings/0001437749-24-016136.md) | [9.4](/filings/0001437749-25-029455.md) | [8.1](/filings/0001437749-24-034421.md) | [6.8](/filings/0001437749-25-003692.md) | [6.3](/filings/0001437749-25-016318.md) | [6.3](/filings/0001437749-26-031124.md) | [12.0](/filings/0001437749-25-034999.md) | [11.7](/filings/0001437749-26-004010.md) | [9.9](/filings/0001437749-26-016914.md) | [13.2](/filings/0001437749-26-031124.md) |
| Total liabilities | $m | [15.0](/filings/0001437749-23-031430.md) | [15.1](/filings/0001437749-24-003714.md) | [11.6](/filings/0001437749-24-016136.md) | [11.0](/filings/0001437749-25-029455.md) | [9.5](/filings/0001437749-24-034421.md) | [7.6](/filings/0001437749-25-003692.md) | [7.2](/filings/0001437749-25-016318.md) | [7.1](/filings/0001437749-26-031124.md) | [13.2](/filings/0001437749-25-034999.md) | [14.0](/filings/0001437749-26-004010.md) | [12.3](/filings/0001437749-26-016914.md) | [17.7](/filings/0001437749-26-031124.md) |
| Long-term debt | $m | [1.2](/filings/0001437749-23-031430.md) | [1.1](/filings/0001437749-24-003714.md) | [1.0](/filings/0001437749-24-016136.md) | [0.9](/filings/0001437749-25-029455.md) | [0.9](/filings/0001437749-24-034421.md) | [0.8](/filings/0001437749-25-003692.md) | [0.7](/filings/0001437749-25-016318.md) | [0.7](/filings/0001437749-26-031124.md) | [0.6](/filings/0001437749-25-034999.md) | [0.6](/filings/0001437749-26-004010.md) | [0.5](/filings/0001437749-26-016914.md) | [0.4](/filings/0001437749-26-031124.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [29.5](/filings/0001437749-23-031430.md) | [31.4](/filings/0001437749-24-003714.md) | [31.2](/filings/0001437749-24-016136.md) | [31.3](/filings/0001437749-25-029455.md) | [33.1](/filings/0001437749-24-034421.md) | [31.8](/filings/0001437749-25-003692.md) | [32.3](/filings/0001437749-25-016318.md) | [34.0](/filings/0001437749-26-031124.md) | [34.1](/filings/0001437749-25-034999.md) | [33.5](/filings/0001437749-26-004010.md) | [34.3](/filings/0001437749-26-016914.md) | [44.9](/filings/0001437749-26-031124.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [24.0](/filings/0001437749-24-034421.md) | [1,343 d](/filings/0001437749-25-003692.md) | [1,151 d](/filings/0001437749-25-016318.md) | [199 d](/filings/0001437749-25-029455.md) | [(1,857)](/filings/0001437749-25-034999.md) | [2,111 d](/filings/0001437749-26-004010.md) | [781 d](/filings/0001437749-26-016914.md) | [(664) d](/filings/0001437749-26-031124.md) | [933](/filings/0001437749-25-034999.md) | [134 d](/filings/0001437749-26-004010.md) | [1,251 d](/filings/0001437749-26-016914.md) | [1,109 d](/filings/0001437749-26-031124.md) |
| Capital expenditure | $k | [77.0](/filings/0001437749-24-034421.md) | [81.0](/filings/0001437749-24-003714.md) | [50.0](/filings/0001437749-24-016136.md) | [334 d](/filings/0001437749-25-029455.md) | [69.0](/filings/0001437749-25-034999.md) | [183 d](/filings/0001437749-26-004010.md) | [156 d](/filings/0001437749-26-016914.md) | [559 d](/filings/0001437749-26-031124.md) | [46.0](/filings/0001437749-25-034999.md) | [286 d](/filings/0001437749-26-004010.md) | [544 d](/filings/0001437749-26-016914.md) | [865 d](/filings/0001437749-26-031124.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-031124.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-031124.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,158](/filings/0001437749-23-031430.md) | [4,162](/filings/0001437749-24-003714.md) | [4,159](/filings/0001437749-24-016136.md) | [4,280](/filings/0001437749-24-034421.md) | [4,259](/filings/0001437749-25-003692.md) | [4,282](/filings/0001437749-25-016318.md) | [4,335](/filings/0001437749-25-034999.md) | [8,807](/filings/0001437749-26-004010.md) | [8,751](/filings/0001437749-26-016914.md) | [4,362](/filings/0001437749-25-034999.md) | [9,364](/filings/0001437749-26-004010.md) | [9,748](/filings/0001437749-26-016914.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,384,698 at 2026-09-01, from the cover of the [10-K filed 2026-09-24](/filings/0001437749-26-031124.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.